Prothena (PRTA)
(Real Time Quote from BATS)
$20.08 USD
-1.51 (-6.99%)
Updated May 23, 2024 03:54 PM ET
After-Market: $20.09 +0.01 (0.05%) 4:12 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
0 items in cart
Prothena Corporation plc [PRTA]
Reports for Purchase
Showing records 141 - 160 ( 330 total )
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
1Q, Prothena in a Difficult Place Post-NEOD001 Discontinuation
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
NEOD001 Discontinued, Company Valued at Cash
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
CELG Collaboration a Positive and Reduces Cash Needs
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
4Q, Staying on Sidelines ahead of High-Risk Data Readouts
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D